Experimental and theoretical protein folding. 1989

R Jernigan, and D Davies, and H Scheraga
Laboratory of Mathematical Biology, National Cancer Institute, Bethesda, Maryland 20892.

UI MeSH Term Description Entries
D009097 Multienzyme Complexes Systems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates. They may involve simply a transfer of water molecules or hydrogen atoms and may be associated with large supramolecular structures such as MITOCHONDRIA or RIBOSOMES. Complexes, Multienzyme
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D003461 Crystallography The branch of science that deals with the geometric description of crystals and their internal arrangement. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystallographies
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated

Related Publications

R Jernigan, and D Davies, and H Scheraga
January 1975, Advances in protein chemistry,
R Jernigan, and D Davies, and H Scheraga
September 2004, Methods (San Diego, Calif.),
R Jernigan, and D Davies, and H Scheraga
March 2004, Proceedings of the National Academy of Sciences of the United States of America,
R Jernigan, and D Davies, and H Scheraga
January 1983, Annual review of biophysics and bioengineering,
R Jernigan, and D Davies, and H Scheraga
January 2010, Annual review of biophysics,
R Jernigan, and D Davies, and H Scheraga
April 2012, Current protocols in protein science,
R Jernigan, and D Davies, and H Scheraga
February 1995, Current opinion in structural biology,
R Jernigan, and D Davies, and H Scheraga
December 2013, Biochemistry,
R Jernigan, and D Davies, and H Scheraga
July 2008, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!